GNS vs. HWDN, DPH, IGG, CTY, SMWH, CAR, PRP, AUK, STG, and BAY
Should you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), Strip Tinning (STG), and Bay Capital (BAY). These companies are all part of the "personal services" industry.
Genus vs. Its Competitors
Howden Joinery Group (LON:HWDN) and Genus (LON:GNS) are both personal services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.
67.4% of Howden Joinery Group shares are held by institutional investors. Comparatively, 63.4% of Genus shares are held by institutional investors. 0.9% of Howden Joinery Group shares are held by insiders. Comparatively, 0.6% of Genus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Howden Joinery Group pays an annual dividend of GBX 0.21 per share and has a dividend yield of 0.0%. Genus pays an annual dividend of GBX 0.32 per share and has a dividend yield of 0.0%. Howden Joinery Group pays out 45.8% of its earnings in the form of a dividend. Genus pays out -516.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
In the previous week, Howden Joinery Group and Howden Joinery Group both had 1 articles in the media. Howden Joinery Group's average media sentiment score of 1.05 beat Genus' score of 0.00 indicating that Howden Joinery Group is being referred to more favorably in the media.
Howden Joinery Group currently has a consensus target price of GBX 919.67, indicating a potential upside of 12.29%. Genus has a consensus target price of GBX 2,725, indicating a potential upside of 9.00%. Given Howden Joinery Group's higher possible upside, analysts clearly believe Howden Joinery Group is more favorable than Genus.
Howden Joinery Group has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Genus has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500.
Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.
Howden Joinery Group has higher revenue and earnings than Genus. Genus is trading at a lower price-to-earnings ratio than Howden Joinery Group, indicating that it is currently the more affordable of the two stocks.
Summary
Howden Joinery Group beats Genus on 13 of the 17 factors compared between the two stocks.
Get Genus News Delivered to You Automatically
Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:GNS) was last updated on 9/3/2025 by MarketBeat.com Staff
Free GNS Stock Alerts